Blar i forfatter "Larsen, Signe Melsen"

Viser treff 1-4 av 4

    • Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours 

      Gerdtsson, Axel; Negaard, Helene Francisca Stigter; Almås, Bjarte; Bergdahl, Anna Grenabo; Cohn-Cedermark, Gabriella; Glimelius, Ingrid; Halvorsen, Dag; Haugnes, Hege Sagstuen; Hedlund, Annika; Hellström, Martin; Holmberg, Göran; Karlsdottir, Åsa; Kjellman, Anders; Larsen, Signe Melsen; Thor, Anna; Wahlqvist, Rolf; Ståhl, Olof; Tandstad, Torgrim (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-01-31)
      Objectives - To assess whether extended surveillance with repeated computed tomography (CT) scans for patients with clinical stage IIA (CS IIA; <2 cm abdominal node involvement) and negative markers (Mk−) non-seminomatous germ cell tumours (NSGCTs) can identify those with true CS I. To assess the rate of benign lymph nodes, teratoma, and viable cancer in retroperitoneal lymph node dissection (RPLND) ...

    • Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience 

      Thor, Anna; Negaard, Helene Francisca Stigter; Grenabo Bergdahl, Anna; Almås, Bjarte; Larsen, Signe Melsen; Lundgren, Per-Olof; Gerdtsson, Axel; Halvorsen, Dag; Johannsdottir, Berglind; Jansson, Anna K.; Hellström, Martin; Wahlqvist, Rolf; Langberg, Carl W.; Hedlund, Annika; Akre, Olof; Glimelius, Ingrid; Ståhl, Olof; Haugnes, Hege Sagstuen; Cohn-Cedermark, Gabriella; Kjellman, Anders; Tandstad, Torgrim (Journal article; Tidsskriftartikkel, 2024-06-11)
      <p><i>Background and objective</i> There is an unmet need to avoid long-term morbidity associated with standard cytotoxic treatment for low-volume metastatic seminoma. Our aim was to assess the oncological efficacy and surgical safety of retroperitoneal lymph node dissection (RPLND) as treatment in a population-based cohort of metastatic seminoma patients with limited retroperitoneal lymphadenopat ...

    • Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group 

      Gerdtsson, Axel; Håkansson, Ulf; Törnblom, Magnus; Jancke, George; Negaard, Helene Francisca Stigter; Glimelius, Ingrid; Halvorsen, Dag; Karlsdottir, Åsa; Haugnes, Hege Sagstuen; Andreassen, Kristine Engen; Larsen, Signe Melsen; Holmberg, Göran; Wahlqvist, Rolf; Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Ståhl, Olof; Kjellmann, Anders (Journal article; Tidsskriftartikkel, 2020-09-08)
      Background - Reports on perioperative complications after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for nonseminoma germ cell tumour (NSGCT) are from experienced single centres, with a lack of population-based studies.<p> <p>Objective - To assess the complications of bilateral and unilateral PC-RPLND.<p> <p>Design, setting, and participants - A prospective, population-based, ...

    • Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients 

      Gerdtsson, Axel; Torisson, Gustav; Thor, Anna; Grenabo Bergdahl, Anna; Almås, Bjarte; Håkansson, Ulf; Törnblom, Magnus; Negaard, Helene Francisca Stigter; Glimelius, Ingrid; Halvorsen, Dag; Karlsdottir, Åsa; Haugnes, Hege Sagstuen; Larsen, Signe Melsen; Holmberg, Göran; Wahlqvist, Rolf; Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Ståhl, Olof; Kjellman, Anders (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-05-02)
      Objective - To validate Vergouwe's prediction model using the Swedish and Norwegian Testicular Cancer Group (SWENOTECA) RETROP database and to define its clinical utility.<p> <p>Materials and methods - Vergouwe's prediction model for benign histopathology in post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) uses the following variables: presence of teratoma in orchiectomy specimen; ...